BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -302.20K | -553.30K | -617.50K | 1.02M | -995.80K |
| Total Depreciation and Amortization | -203.20K | 152.80K | 163.80K | 223.80K | 205.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.10K | 141.70K | 147.50K | -205.00K | 105.30K |
| Change in Net Operating Assets | 391.80K | 458.80K | -446.70K | -889.20K | 946.90K |
| Cash from Operations | 24.50K | 200.00K | -752.90K | 152.50K | 261.50K |
| Capital Expenditure | -9.70K | -39.70K | -- | -3.60K | -1.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -1.00K |
| Cash from Investing | -9.70K | -39.70K | -- | -3.60K | -2.50K |
| Total Debt Issued | -- | -- | -- | 1.13M | 336.30K |
| Total Debt Repaid | -100.50K | -90.90K | -95.40K | -105.40K | -94.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -124.60K | -67.20K | -198.10K | -499.10K | 800.00 |
| Cash from Financing | -165.00K | -115.50K | -217.70K | 388.70K | 180.80K |
| Foreign Exchange rate Adjustments | 473.80K | -128.70K | -82.80K | 269.80K | -193.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 323.60K | -84.00K | -1.05M | 807.40K | 245.90K |
